Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells.

Yang MY, Lin PM, Liu YC, Hsiao HH, Yang WC, Hsu JF, Hsu CM, Lin SF.

PLoS One. 2012;7(5):e37205. doi: 10.1371/journal.pone.0037205. Epub 2012 May 11.

2.

miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts.

Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G.

Physiol Genomics. 2009 Nov 6;39(3):210-8. doi: 10.1152/physiolgenomics.00085.2009. Epub 2009 Sep 1.

PMID:
19723773
3.

DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells.

Zhang Y, Gao Y, Zhang G, Huang S, Dong Z, Kong C, Su D, Du J, Zhu S, Liang Q, Zhang J, Lu J, Huang B.

Int J Cancer. 2011 Feb 1;128(3):551-61. doi: 10.1002/ijc.25365.

4.

MicroRNA alterations in senescent endothelial progenitor cells induced by remnant-like lipoproteins.

Yang DG, Liu L, Zhou SH.

Chin Med J (Engl). 2012 Oct;125(19):3479-84.

PMID:
23044309
5.

Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin.

Di X, Shiu RP, Newsham IF, Gewirtz DA.

Biochem Pharmacol. 2009 Apr 1;77(7):1139-50. doi: 10.1016/j.bcp.2008.12.016. Epub 2009 Jan 6.

PMID:
19185564
6.

Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage.

Maejima Y, Adachi S, Ito H, Hirao K, Isobe M.

Aging Cell. 2008 Mar;7(2):125-36. Epub 2007 Nov 21.

7.
8.

Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells.

Seca H, Lima RT, Lopes-Rodrigues V, Guimaraes JE, Almeida GM, Vasconcelos MH.

Curr Drug Targets. 2013 Sep;14(10):1135-43.

PMID:
23834154
9.

Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.

Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, Roninson IB.

Oncogene. 1999 Aug 26;18(34):4808-18.

10.

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.

Tazawa H, Tsuchiya N, Izumiya M, Nakagama H.

Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7. Epub 2007 Sep 17.

11.

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.

Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB.

Cancer Biol Ther. 2008 Aug;7(8):1288-96. Epub 2008 Aug 13.

PMID:
18497571
12.

miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.

Shang J, Yao Y, Fan X, Shangguan L, Li J, Liu H, Zhou Y.

Biochim Biophys Acta. 2016 Apr;1863(4):520-32. doi: 10.1016/j.bbamcr.2016.01.005. Epub 2016 Jan 11.

14.
15.
16.

Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells.

Li G, Luna C, Qiu J, Epstein DL, Gonzalez P.

Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2976-85. doi: 10.1167/iovs.09-4874. Epub 2010 Jan 6.

17.

MicroRNA 299-3p modulates replicative senescence in endothelial cells.

Jong HL, Mustafa MR, Vanhoutte PM, AbuBakar S, Wong PF.

Physiol Genomics. 2013 Apr 1;45(7):256-67. doi: 10.1152/physiolgenomics.00071.2012. Epub 2013 Jan 29.

PMID:
23362143
18.

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, Pilpel Y, Nielsen FC, Oren M, Lund AH.

Cell Death Differ. 2010 Feb;17(2):236-45. doi: 10.1038/cdd.2009.109. Epub 2009 Aug 21.

19.

miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.

Navarro F, Gutman D, Meire E, Cáceres M, Rigoutsos I, Bentwich Z, Lieberman J.

Blood. 2009 Sep 3;114(10):2181-92. doi: 10.1182/blood-2009-02-205062. Epub 2009 Jul 7.

20.

Supplemental Content

Support Center